NCT04508049View on ClinicalTrials.gov

A Study to Evaluate Renal Fibrosis Using MRI Techniques

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
HypertensionRenovascular
Interventions
DEVICE

qMT-MRI to detect fibrosis.

The hypothesis underlying this proposal is that qMT would reliably detect development of renal fibrosis at both 1.5T and 3.0T in subjects with RVD. Patients will be studied with MRI (for fibrosis) and CT (for renal function).

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT04508049 - A Study to Evaluate Renal Fibrosis Using MRI Techniques | Biotech Hunter | Biotech Hunter